Post by ZEISS Vision

📍 #ARVO2026 | New Clinical Evidence in Myopia Management At ZEISS Vision, we are looking forward to sharing new clinical insights on novel myopia control spectacle lenses, with multiple presentations featured across poster and paper sessions. The program will spotlight evidence spanning 6 months to 3 years, including: 👁️‍🗨️ Efficacy outcomes of myopia control across different study designs. 👁️‍🗨️ Responder vs. non‑responder insights from clinical trials on #MyopiaControl spectacle lenses. 👁️‍🗨️ Risk factors in #MyopiaProgression. 👁️‍🗨️ Clinical results on Cylindrical Annular Refractive Elements (CARE). 👉 Visit us at Poster Hall or Mile High 2A/2A to meet our expert #EyeCare team behind this research and discuss how we are shaping the future of #MyopiaManagement through clinical evidence and expert insights. * Not all myopia control solutions are available in every country; availability begins in April and may vary by market.